New diagnostic techniques for breast cancer detection

Future Oncology

Volumn 4, Issue 4, 2008, Pages 501-513

  Singh, Vineeta ^a   Saunders, Christobel ^a   Wylie, Liz ^b   Bourke, Anita ^c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

^c SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

Breast cancer; Cancer detection; Imaging; Indeterminate lesions; Screening

Indexed keywords

17ALPHA IODOVINYL 11 BETA ESTRADIOL 3 METHYL ETHER; AMINO ACID; ESTROGEN DERIVATIVE; FLUORODEOXYGLUCOSE F 18; TAMOXIFEN; TECHNETIUM 99M; UNCLASSIFIED DRUG; VOLATILE ORGANIC COMPOUND;

BREAST CANCER; BREATH ANALYSIS; CANCER RECURRENCE; CLINICAL TRIAL; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED RADIOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DIFFRACTION; DIGITAL MAMMOGRAPHY; DUCTAL LAVAGE; EARLY DIAGNOSIS; ECHOMAMMOGRAPHY; ELASTOGRAPHY; HAIR TEST; HUMAN; IMAGE DISPLAY; IMAGE QUALITY; MAMMARY DUCTOSCOPY; METASTASIS; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOLOGIST; REVIEW; SCINTIMAMMOGRAPHY; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT RESPONSE;

ADULT; AGED; BREAST NEOPLASMS; BREATH TESTS; DIAGNOSTIC IMAGING; ELASTICITY IMAGING TECHNIQUES; ENDOSCOPY; FEMALE; HAIR; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IRRIGATION; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, OPTICAL COHERENCE; TOMOGRAPHY, X-RAY COMPUTED; X-RAY DIFFRACTION;

EID: 55449089707     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/14796694.4.4.501     Document Type: Review

References (91)

1. Fischer U, Baum F, Obenauer S, Luftner-Nagel S, von Heyden D, Vosshenrich R: Comparative study in patients with microcalcifications: full-field digital mammography vs screen-film mammography. Eur Radiol. 12, 2679-2683 (2002).
2. Berry DA: Benefits and risks of screening mammography for women in their forties: a statistical appraisal. J. Natl Cancer Inst. 90, 1431-1439 (1998).
3. Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE: Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 359, 909-919 (2002).
4. Gotzsche PC, Olsen O: Is screening for breast cancer with mammography justifiable? Lancet 355, 129-134 (2002).
5. Health Council of The Netherlands: The Benefit of Population Screnning for Breast Cancer with Mammography. Health Council of the Netherlands, The Hague, The Netherlands 03(E) (2002).
6. Mandelson MT, Oestreicher N, Porter PL et al.: Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J. Natl Cancer Inst. 92, 1081-1087 (2000).
7. Carney PA, Miglioretti DL, Yankaskas BC et al.: Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann. Intern. Med. 138, 168-175 (2003).
8. Brown ML, Houn F, Sickles EA, Kessler LG: Screening mammography in community practice: positive predictive value of abnormal findings and yield of follow-up diagnostic procedures. AJR Am. J. Roentgenol. 165, 1373-1377 (1995).
9. Barton MB, Moore SM, Polk S, Shtatland E, Elmore JG, Fletcher SW: Increased patient concern after false-positive mammograms: clinician documentation and subsequent ambulatory visits. J. Gen. Intern. Med. 16, 150-156 (2001).
10. Christiansen CL, Wang F, Barton MB et al.: Predicting the cumulative risk of false-positive mammograms. J. Natl Cancer Inst. 92, 1657-1666 (2000).
11. Ma L, Fishell EK, Wright B, Hanna W, Allan S, Boyd NF: Case-control study of factors associated with failure to detect breast cancer by mammography. J. Natl Cancer Inst. 84, 781-785 (1992).
12. Feig SA, Yaffe MJ: Digital mammography, computer-aided diagnosis, and telemammography. Radiol. Clin. North Am. 33, 1205-1230 (1995).
13. Kegelmeyer WP, Pruneda JM, Bourland PD et al.: Computer-aided mammographic screening for spiculated lesions. Radiology 191, 331-337 (1994).
14. Pisano ED, Gatsonis C, Hendrick E et al.: Diagnostic performance of digital versus film mammography for breast-cancer screening. N. Engl. J. Med. 353, 1773-1783 (2005).
15. Fischmann A, Seigmann KC, Wersebe A, Clausenn CD: Comparison of full-field digital mammography and film-screen mammography: image quality and lesion detection. Br. J. Radiol. 78, 312-315 (2005).
16. Lewin JM, D'Orsi CJ, Hendrick RE, Moss LJ, Isaacs PK, Karellas A: Clinical comparison of full-field digital mammography and screen-film mammography for detection of breast cancer. AJR Am. J. Roentgenol. 179, 671-677 (2002).
17. Freer TW, Ulissey MJ: Screening mammography with computer-aided detection: prospective study of 12,860 patients in a community breast center. Radiology 220, 781-786 (2001).
18. Gur D, Sumkin JH, Rockette HE et al.: Changes in breast cancer detection and mammography recall rates after the introduction of a computer-aided detection system. J Natl Cancer Inst. 96, 185-190 (2004).
19. Vyborny CJ: Can computers help radiologists read mammograms? Radiology 191, 315-317 (1994).
20. Warren Burhenne LJ, Wood SA, D'Orsi CJ et al.: The potential contribution of computer-aided detection to the sensitivity of screening mammography. Radiology 215, 554-562 (2000).
21. Hendee WR, Beam C, Hendrick E: Proposition: all mammograms should be double-read. Med. Phys. 26, 115-118 (1999).
22. Freer TW, Ulissey MJ: Screening mammography with computer-aided detection: prospective study of 12,860 patients in a community breast center. Radiology 220, 781-786 (2001).
23. Jiang Y, Nishikawa RM, Schmidt RA et al.: Improving breast cancer diagnosis with computer-aided diagnosis. Acad. Radiol. 6, 22-33 (1999).
24. Fenton JJ, Taplin SH, Carney PA et al.: Influence of computer-aided detection on performance of screening mammogram. N. Engl. J. Med. 356(14), 1399-1409 (2007).
25. Planche K, Vinnicombe S: Breast imaging in the new era. Cancer Imaging 4(2), 39-50 (2004).
26. Kuhl CK, Mielcareck P, Klaschik S et al.: Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 211(1), 101-110 (1999).
27. Kuhl CK, Schild HH, Morakkabati N: Dynamic bilateral contrast enhanced MR imaging of breast: trade off between spatial and temporal resolution. Radiology 236(3), 789-800 (2005).
28. Diekmann F, Diekmann S, Jeunehomme F, Muller S, Hamm B, Bick U: Digital mammography using iodine based contrast media: initial clinical experience with dynamic contrast medium enhancement. Invest. Radio. 40(7), 397-404 (2005).
29. Diekmann F, Bick U: Tomosynthesis and contrast-enhanced digital mammography: recent advances in digital mammography. Eur. Radiol. 17, 3086-3092 (2007).
30. Diekmann F, Diekmann S, Richter K et al.: Near monochromatic x-rays for digital slot-scan mammography: initial findings. Eur. Radiol. 14(9), 1641-1646 (2004).
31. Rakowski JT, Dennis MJ: A comparison of reconstruction algorithms for c-arm mammography tomosynthesis. Med Phys. 33(8), 3018-3032 (2006).
32. Poplack SP, Tosteson TD, Kogel CA, Nagy HM: Digital breast tomosynthesis: initial experience in 98 women with abnormal digital screening mammography. Am. J. Roentgenol. 189(3), 616-623 (2007).
33. Gordon PB: Ultrasound for breast cancer screening and staging. Radiol. Clin. N. Am. 40, 431-441 (2002).
34. Crystal P, Strano SD, Shcharynski S et al.: Using sonography to screen women with mammographically dense breasts. AJR Am. J. Roentgenol. 181, 177-182 (2003).
35. Harvey JA: Sonography of palpable breast masses. Semin. Ultrasound CT MR 27(4), 284-297 (2006).
36. Berg WA: Beyond standard mammographic screening: mammography at age extremes, ultrasound, and MR imaging. Radiol. Clin. North Am. 45 (5), 895-906 (2007).
37. Yang WT, Ahuja A, Tang A et al.: High resolution sonographic detection of axillary lymph node metastases in breast cancer. J Ultrasound Med. 15 (3), 241-246 (1996).
38. Berg WA, Blume JD, Cormack JB, Mendelson EB, Madsen EL; ACRIN 6666 Investigators: Lesion detection and characterization in a breast US phantom: results of the ACRIN 6666. Radiology 239(3), 693-702 (2006).
39. Bluemke DA, Gatsonis CA, Chen MH et al.: MR imaging prior to breast biopsy: results of the International Breast Magnetic Resonance Consortium (IBMC) trial. JAMA 292, 2735-2742 (2004).
40. Heywang-Köbrunner SH, Viehweg P, Heinig A, Kuchler C: Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. Eur. J. Radiol. 24, 94-108 (1997).
41. Gilles R, Guinebretiere JM, Shapeero LG et al.: Assessment of breast cancer recurrence with contrast-enhanced subtraction MR imaging: preliminary results in 26 patients. Radiology 188(2), 473-478 (1993).
42. Warner E, Plewes DB, Hill KA et al.: Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292, 1317-1325 (2004).
43. Saslow D, Boetes C, Burke W et al.: American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J. Clin. 57, 75-89 (2007).
44. Olson JA Jr, Morris EA, van Zee KJ, Linehan DC, Borgen PI: Magnetic resonance imaging facilitates breast conservation for occult breast cancer. Ann. Surg. Oncol. 7, 411-415 (2000).
45. Herrada J, Iyer RB, Atkinson EN, Sneige N, Buzdar AU, Hortobagyi GN: Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma. Clin. Cancer Res. 3, 1565-1169 (1997).
46. Balu-Maestro C, Chapellier C, Bleuse A, Chanalet I, Chauvel C, Largillier R: Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI. Breast Cancer Res. Treat. 72, 145-152 (2002).
47. Warren RM, Crawely A: Is breast MRI ever useful in a mammographic screening programme? Clin. Radiol. 57, 1090-1097 (2002)
48. Gorczyca DP, Sinha S, Ahn CY et al.: Silicone breast implant in vivo: MR imaging. Radiology 185, 407-410 (1992).
49. van Goethem M, Schelfout K, Dijckmans L et al.: MR mammography in the pre-operative staging of breast cancer in patients with dense breast tissue: comparison with mammography and ultrasound. Eur. Radiol. 14, 809-816 (2004).
50. Liberman L, Morris EA, Kim CM et al.: MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am. J. Roentgenol. 180, 333-331 (2003).
51. Bedrosian I, Mick R, Orel SG et al.: Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 98, 468-473 (2003).
52. Buck A, Schirrmeister H, Kuhn T: FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters. Eur. J. Nucl. Mol. Imaging 29, 1317-1323 (2002).
53. Avril N, Rose CA, Schelling M et al.: Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations. J. Clin. Oncol. 18, 3495-3502 (2000).
54. Smith IC, Welch AE, Hutcheon AW et al.: Positron emission tomography using [18F]-fluorodeoxy-D-glucose to the pathological response of breast cancer to primary chemotherapy. J. Clin. Oncol. 18, 1676-1688 (2000).
55. Grahek D, Montravers F, Kerrou K et al.: [18F]FDG in recurrent breast cancer: diagnostic performances, clinical impact and relevance of induced changes in management. Eur. J. Nucl. Med. Mol. Imaging 31, 179-188 (2004).
56. Schirrmeister H, Kuhn T, Guhlmann A et al.: Fluorine 18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with standard staging procedures. Eur. J. Nucl. Med. 28, 351-358 (2001).
57. Tatsumi M, Cohade C, Mourtzikos KA, Fishman EK: Initial experience with FDG-PET/CT in the evaluation of breast cancer. Eur. J. Nucl. Med. Mol. Imaging 33, 254-262 (2006).
58. Sang KY, Nariya C, Woo KM: The role of PET/CT for evaluating breast cancer. Korean J. Radiol. 8, 429-437 (2007).
59. Taillefer R: The role of 99m Tc sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis. Semin. Nucl. Med. 29, 16-40 (1999).
60. Liberman M, Sampalls F, Mulder DS, Sampalia JS: Breast cancer diagnosis by scintimammography meta-analysis and review of the literature. Breast Cancer Res. Treat. 80, 115-126 (2003).
61. Kim R, Osaki A, Hirai T, Toge T: Utility of technetium -99m methoxyisobutyl isonitryl uptake analysis for prediction of the response to chemotherapy in advanced and relapsed breast cancer. Breast Cancer 9, 240-247 (2002).
62. Cwikla JB, Buscombe JR, Kolaainska AD, Holloway B, Hilson AJ: Evaluation of scintimammography as an additional test to conventional mammography in detection of breast cancer. Ginekol. Pol. 74, 362-370 (2003).
63. Mankoff DA, Dunnwald LK, Gralow JR et al.: Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using Tc 99m-sestamibi scintimammography. Cancer 85, 2410-2423 (1999).
64. Marshall C, Eremin J, El-Sheemy M, Eremin O, Griffitha PA: Monitoring the response of large (>3cm) and locally advanced (T3-4,NO-2) breast cancer to neoadjuvant chemotherapy using 99mTc- sestamibi uptake. Nuc. Med. Conunun. 26, 9-15 (2005).
65. Shields AF, Grierson JR, Dohmen BM et al.: Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat. Med. 4, 1334-1336 (1998).
66. Amano S, Inoue T, Tomiyishi K, Ando T, Endo K: In vivo comparison of PET and SPECT radiopharmaceuticals in detecting breast cancer. J. Nuc. Med. 39, 1424-1427 (1998).
67. Huovinen R, Leakinen-Kallio S, Nagren K et al.: Carbon 11-methionine and PET in evaluation of treatment response of breast cancer. Br. J. Cancer 67, 787-791 (1993).
68. Bennink Rj, van Tienhoven G, Rijka IJ, Noorduyn AL, Janssen AG: In vivo prediction of response to antiestrogen treatment in estrogen positive breast cancer. J. Nucl. Med. 45, 4900-4905 (2004).
69. McKnight AL, Kugel JL, Rossman PJ et al.: MR elastography of breast cancer: preliminary results. AJR Am. J. Roentgenol. 178(6), 1411-1417 (2002).
70. Sinkus R, Siegmarm K, Xydeas T et al.: MR elastography of breast lesions: understanding the solid/liquid duality can improve the specificity of contmt-enhanced MR mammography. Magn. Reson. Med. 58(6), 1135-1144 (2007).
71. Sauter ER, Shan S, Hewett JE et al.: Proteonomic analysis of nipple aspirate fluid using SELDI-TOF-MS. Int. J. Cancer 114, 791-796 (2005).
72. Paterok EM, Rosenthal H, Sabel M: Nipple discharge and abnormal galactogram. Results of a long-term study (1964-1990). Eur. J. Obstet. Gynecol. Reprod. Biol. 50, 227-234 (1993).
73. Dietz JR, Crowe JP, Grundfest S et al.: Directed duct excision by using mammary ductoscopy in patients with pathologic nipple discharge. Surgery 132, 582-587 (2002).
74. Matsunaga T Kawakami Y, Namba K et al.: Intraductal biopsy for diagnosis and treatment of intraductal lesions of the breast. Cancer 101, 2164-2169 (2004).
75. Demos SG, Vogel AJ, Gandjbakhche AH: Advances in optical spectroscopy and imaging of breast lesions. J. Mammary Gland. Biol. Neoplasia 11, 165-181 (2006).
76. Huang D, Swanson EA, Lin CP et al.: Optical coherence tomography. Science 254(5035), 1178-1181 (1991).
77. Shafer-Peltier K, Haka A, Fitzmaurice M et al.: Raman microspectroscopic model of human breast tissue: implications for breast cancer diagnosis in vivo. J. Raman. Spectrosc. 33(7), 552-563 (2002).
78. Dukor R, Liebman M, Johnson B: A new, non-destructive method for analysis of clinical samples with FT-IR microspectroscopy breast cancer tissue as an example. Cell Mol. Biol. 44(1), 211-217 (1998).
79. Ci Y, Gao T, Feng J. Guo Z: Fourier transform infrared spectroscopic characterization of human breast tissue: implications for breast cancer diagnosis. Applied Spectrosc. 53(3), 312-315 (1999).
80. Wallon J, Yan S, Tong J, Meurens M, Haot J: Identification of breast carcinomatous tissue by near-infrared reflectance spectroscopy. Applied Spectroscopy 48(2), 190-193 (1994).
81. Yang Y, Celmer E, Koutcher J, Alfano R: UV reflectance spectroscopy probes DNA and protein changes in human breast tissues. J. Clin. Laser Med. Surg. 19(1), 35-39 (2001).
82. Achilefu S, Dorshow RB, Bugaj JE, Rajagopalan R: Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging. Invest. Radiol. 35(8), 479-485 (2000).
83. Ambrosone CB: Oxidants and antioxidants in breast cancer. Antioxid. Redox Signal 2, 903-917 (2000).
84. Kneepkens CM, Lepage G, Roy CC: The potential of the hydrocarbon breath test as a measure of lipid peroxidation. Free Radic. Biol. Med. 17, 127-160 (1994).
85. Phillips M, Cataneo RN, Ditkoff BA et al.: Volatile markers of breast cancer in the breath. Breast J. 9(3), 184-191 (2003).
86. James V, Kearsley J, Irving T, Amemiya Y, Cookson D: Using hair to screen for breast cancer. Nature 398, 33-34 (1999).
87. Feughelman M, James VJ: Hexagonal packing of intermediate filaments in α-keratin fibers. Textile Res. J. 68, 110-114 (1998).
88. James V, Kearsley J, Irving T, Amemiya Y et al.: Using hair to screen for breast cancer. Nature 398, 33-34 (1999).
89. James V, Corino G, Robertson T et al.: Early diagnosis of breast cancer by hair diffraction. Int. J. Cancer 114, 969-972 (2005).
90. James V: A place for fiber diffraction in the detection of breast cancer. Cancer Detect. Prev. 30(3), 233-238 (2006).
91. Laaziri K, Sutton M, Ghadirian P et al.: Is there a correlation between the structure of hair and breast cancer or BRCA1/2 mutations? Phys. Med. Biol. 47(10), 1623-1623(2002).